Transaction · 0001193125-26-422957

Cha Albert

Cha Albert, CEO, reported an open-market or private purchase at Frazier Life Sciences Acquisition Corp. II involving 300000.000000 shares for an estimated $3000000.00. Reported holdings after the transaction were 300000.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market buySEC transaction code PCEO
FLSCFrazier Life Sciences Acquisition Corp. II
Trade date
Oct 15, 2026
Filing date
Oct 15, 2026
View on SEC Insider profile
Estimated value$3.00MShares × reported price
Shares traded300k$10.00 per share
Holdings after300kIndirect · By Frazier Life Sciences Holdings II LLC
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

New position: there is no prior reported position to use as a percentage baseline.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

FLSC price since this filing

Daily closing prices, with the filing date and available return windows
FLSC · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago1d ago
Returns since7d30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Buy
Code P
Identifier
0001193125-26-422957
Class A ordinary shares
Transaction date
Oct 15, 2026
Filed Oct 15, 2026, 08:40 PM · 0d delay
Shares
300,000 sh
$10.00 per share
Estimated value
$3.00M
Computed from shares × price
Holdings after
300,000 sh
Indirect · By Frazier Life Sciences Holdings II LLC

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
CEO Buy Cluster Buy Director Buy Large Buy Large Holdings Increase 10% Owner Buy
Filing-only score

+60 points

Compact filing score computed from stored Form 4 facts. Version v1.

Strong filing signal

This filing has a high positive filing-only score. It may deserve closer research, but it is not an investment recommendation.

How this score is calculated
  • open_market_purchase+12 points

    transaction_code = P

    Code P is a discretionary open-market purchase.
  • ceo_buy+12 points

    is_officer + officer_title/role mentions CEO

    CEO open-market purchase.
  • cluster_buy+14 points

    cluster-buy signal matched

    Multiple insiders bought within the configured window.
  • large_buy_absolute+10 points

    large-buy signal with absolute_triggered = true

    Open-market purchase exceeds the configured absolute threshold.
  • large_holdings_increase+8 points

    large-holdings-increase signal matched

    Reported acquired shares meet the configured percentage of post-transaction holdings.
  • timely_filing+4 points

    reporting_delay_days = 0

    Filing reported within two business days of the transaction.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Executive Officer

Officer YesDirector Yes10% YesOther No
Footnotes & amended
  1. F1

    Securities held by Frazier Life Sciences Holdings II LLC ("Sponsor"). Albert Cha is the sole manager of Sponsor, and Frazier Life Sciences Public Fund, L.P. is its sole equity holder. FHMLSP, L.P. is…

Original filing · 0001193125-26-422957
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

FLSC